1-4 of 4
Ravi Bhatia, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Small Molecules Targeting Rad51 Recombinase Synergize with Imatinib and Overcome Imatinib-Resistance in CML.

Longen Zhou, PhD, Jiewen Zhu, Ph.D., Heiko Konig, M.D., Xiaoqin Lin, Ph.D., Ravi Bhatia, M.D., A. Richard Chamberlin, Ph.D., Phang-Lang Chen, Ph.D., Wen-Hwa Lee, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 466.
https://doi.org/10.1182/blood.V110.11.466.466
Published: 2007
Journal Articles

Effective Induction of Apoptosis in Chronic Myeloid Leukemia CD34+ Cells by the Histone Deacetylase Inhibitor LAQ824 in Combination with Imatinib.

Adam C. Strauss, BA, Su Chu, M.D., Tessa Holyoake, M.D., Ravi Bhatia, M.D.
Journal: Blood
Blood (2007) 110 (11): 1031.
https://doi.org/10.1182/blood.V110.11.1031.1031
Published: 2007
Journal Articles

A Novel Assay for Development of Chromosomal Lesions in Human CD34+ Cells Following Exposure to Ionizing Radiation Reveals Increased Susceptibility To Acquire Unstable Chromosomal Lesions in CML CD34+ Cells.

Sujata Chakraborty, PhD, Arjun Sehgal, Stephen Forman, M.D, Smita Bhatia, M.D, Ravi Bhatia, M.D
Journal: Blood
Blood (2007) 110 (11): 997.
https://doi.org/10.1182/blood.V110.11.997.997
Published: 2007
Journal Articles

Effects of Elevated BCR/ABL Expression Level on Cellular Transformation and Sensitivity to Imatinib in Primitive Human Hematopoietic Cells.

Hardik Modi, MS, Su Chu, M.D, Tinisha McDonald, BS, Stephen Forman, M.D, Ravi Bhatia, M.D
Journal: Blood
Blood (2005) 106 (11): 1998.
https://doi.org/10.1182/blood.V106.11.1998.1998
Published: 2005